ABSTRACT
Protein arginine methylation regulates several cellular events, including epigenetics, splicing, translation, and stress response, among others. This posttranslational modification is catalyzed by protein arginine methyltransferases (PRMTs), which according to their products are classified from type I to type IV. The type I produces monomethyl arginine and asymmetric dimethyl arginine; in mammalian there are six families of this PRMT type (PRMT1, 2, 3, 4, 6, and 8). The protozoa parasite Entamoeba histolytica has four PRMTs related to type I; three of them are similar to PRMT1, but the other one does not show significant homology to be grouped in any known PRMT family, thus we called it as atypical PRMT (EhPRMTA). Here, we showed that EhPRMTA does not contain several of the canonical amino acid residues of type I PRMTs, confirming that it is an atypical PRMT. A specific antibody against EhPRMTA localized this protein in cytoplasm. The recombinant EhPRMTA displayed catalytic activity on commercial histones and the native enzyme modified its expression level during heat shock and erythrophagocytosis. Besides, the knockdown of EhPRMTA produced an increment in cell growth, and phagocytosis, but decreases cell migration and the survival of trophozoites submitted to heat shock, suggesting that this protein is involved in regulate negatively or positively these events, respectively. Thus, results suggest that this methyltransferase regulates some cellular functions related to virulence and cell surviving.
Subject(s)
Entamoeba histolytica/enzymology , Entamoeba histolytica/pathogenicity , Protein-Arginine N-Methyltransferases/metabolism , Amino Acid Sequence , Cell Movement , Cell Proliferation/physiology , Conserved Sequence , Entamoeba histolytica/cytology , Entamoeba histolytica/metabolism , Erythrocytes/metabolism , Gene Expression Regulation, Enzymologic , Gene Knockdown Techniques , Heat-Shock Response/physiology , Phagocytosis , Protein Processing, Post-Translational/physiology , Protein-Arginine N-Methyltransferases/classification , Protein-Arginine N-Methyltransferases/genetics , VirulenceABSTRACT
Protein arginine methyltransferase (PRMT) enzymes play a crucial role in RNA splicing, DNA damage repair, cell signaling, and differentiation. Arginine methylation is a prominent posttransitional modification of histones and various non-histone proteins that can either activate or repress gene expression. The aberrant expression of PRMTs has been linked to multiple abnormalities, notably cancer. Herein, we review a number of non-histone protein substrates for all nine members of human PRMTs and how PRMT-mediated non-histone arginine methylation modulates various diseases. Additionally, we highlight the most recent clinical studies for several PRMT inhibitors.
Subject(s)
Arginine/metabolism , Cardiovascular Diseases/enzymology , Metabolic Diseases/enzymology , Neoplasms/enzymology , Protein Processing, Post-Translational , Protein-Arginine N-Methyltransferases/metabolism , Transcription Factors/metabolism , Antineoplastic Agents/therapeutic use , Cardiovascular Diseases/genetics , Cardiovascular Diseases/pathology , Enzyme Inhibitors/therapeutic use , Epigenesis, Genetic , Histones/genetics , Histones/metabolism , Humans , Metabolic Diseases/genetics , Metabolic Diseases/pathology , Methylation , Neoplasms/drug therapy , Neoplasms/genetics , Neoplasms/pathology , Protein-Arginine N-Methyltransferases/antagonists & inhibitors , Protein-Arginine N-Methyltransferases/classification , Protein-Arginine N-Methyltransferases/genetics , RNA Splicing , Signal Transduction , Transcription Factors/antagonists & inhibitors , Transcription Factors/classification , Transcription Factors/geneticsABSTRACT
The absence of efficient mass spectrometry-based approaches for the large-scale analysis of protein arginine methylation has hindered the understanding of its biological role, beyond the transcriptional regulation occurring through histone modification. In the last decade, however, several technological advances of both the biochemical methods for methylated polypeptide enrichment and the computational pipelines for MS data analysis have considerably boosted this research field, generating novel insights about the extent and role of this post-translational modification. Here, we offer an overview of state-of-the-art approaches for the high-confidence identification and accurate quantification of protein arginine methylation by high-resolution mass spectrometry methods, which comprise the development of both biochemical and bioinformatics methods. The further optimization and systematic application of these analytical solutions will lead to ground-breaking discoveries on the role of protein methylation in biological processes.
Subject(s)
Arginine/metabolism , Mass Spectrometry/methods , Peptides/chemistry , Protein Processing, Post-Translational , Protein-Arginine N-Methyltransferases/metabolism , Animals , Epigenesis, Genetic , Humans , Isoenzymes/chemistry , Isoenzymes/classification , Isoenzymes/genetics , Isoenzymes/metabolism , Methylation , Peptides/metabolism , Protein Interaction Domains and Motifs , Protein-Arginine N-Methyltransferases/chemistry , Protein-Arginine N-Methyltransferases/classification , Protein-Arginine N-Methyltransferases/genetics , Proteomics/methods , Sequence Analysis, Protein , Signal Transduction , Substrate SpecificityABSTRACT
Protein arginine methylation is a widespread eukaryotic posttranslational modification that occurs with as much frequency as ubiquitinylation. Yet, how the nine different human protein arginine methyltransferases (PRMTs) recognize their respective protein targets is not well understood. This review summarizes the progress that has been made over the last decade or more to resolve this significant biochemical question. A multipronged approach involving structural biology, substrate profiling, bioorthogonal chemistry and proteomics is discussed.
Subject(s)
Arginine/metabolism , Peptides/chemistry , Protein Processing, Post-Translational , Protein-Arginine N-Methyltransferases/metabolism , Animals , Epigenesis, Genetic , Histones/genetics , Histones/metabolism , Humans , Isoenzymes/chemistry , Isoenzymes/classification , Isoenzymes/genetics , Isoenzymes/metabolism , Methylation , Models, Molecular , Peptides/metabolism , Protein Interaction Domains and Motifs , Protein Structure, Secondary , Protein-Arginine N-Methyltransferases/chemistry , Protein-Arginine N-Methyltransferases/classification , Protein-Arginine N-Methyltransferases/genetics , Proteomics/methods , Signal Transduction , Substrate SpecificityABSTRACT
The methylation of proteins is integral to the execution of many important biological functions, including cell signalling and transcriptional regulation. Protein methyltransferases (PMTs) are a large class of enzymes that carry out the addition of methyl marks to a broad range of substrates. PMTs are critical for normal cellular physiology and their dysregulation is frequently observed in human disease. As such, PMTs have emerged as promising therapeutic targets with several inhibitors now in clinical trials for oncology indications. The discovery of chemical inhibitors and antagonists of protein methylation signalling has also profoundly impacted our general understanding of PMT biology and pharmacology. In this review, we present general principles for drugging protein methyltransferases or their downstream effectors containing methyl-binding modules, as well as best-in-class examples of the compounds discovered and their impact both at the bench and in the clinic.
Subject(s)
Histone-Lysine N-Methyltransferase/metabolism , Precision Medicine , Allosteric Regulation , Binding Sites , Catalytic Domain , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/therapeutic use , Histone-Lysine N-Methyltransferase/antagonists & inhibitors , Histone-Lysine N-Methyltransferase/classification , Humans , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Protein Processing, Post-Translational , Protein-Arginine N-Methyltransferases/antagonists & inhibitors , Protein-Arginine N-Methyltransferases/classification , Protein-Arginine N-Methyltransferases/metabolismABSTRACT
Nine protein arginine methyltransferases (PRMTs) are conserved in mammals and fish. Among these, PRMT1 is the major type I PRMT for asymmetric dimethylarginine (ADMA) formation and is the most conserved and widely distributed one. Two chicken prmt1 splicing variants were assembled and confirmed by RT-PCR experiments. However, only two scaffolds containing single separate prmt1 exon with high GC contents are present in the current chicken genome assembly. Besides, prmt1 exons are scattered in separate small scaffolds in most avian species. Complete prmt1 gene has only been predicted from two falcon species with few neighboring genes. Crocodilians are considered close to the common ancestor shared by crocodilians and birds. The gene arrangements around prmt1 in American alligator are different from that in birds but are largely conserved in human. Orthologues of genes in a large segment of human chromosomal 19 around PRMT1 are missing or not assigned to the current chicken chromosomes. In comparison, prmt8, the prmt1 paralogue, is on chicken chromosome 1 with the gene arrangements downstream of prmt8 highly conserved in birds, crocodilians, and human. However, the ones upstream vary greatly in birds. Biochemically, we found that though prmt1 transcripts were detected, limited or none PRMT1 protein was present in chicken tissues. Moreover, a much higher level of PRMT8 protein was detected in chicken brain than in mouse brain. While PRMT8 is brain specific in other vertebrate species studied, low level of PRMT8 was present in chicken but not mouse liver and muscle. We also showed that the ADMA level in chicken was similar to that in mouse. This study provides the critical information of chicken PRMT1 and PRMT8 for future analyses of the function of protein arginine methyltransferases in birds.
Subject(s)
Biological Evolution , Brain/enzymology , Chromosome Aberrations , Gene Order , Protein-Arginine N-Methyltransferases/metabolism , Vertebrates/metabolism , Amino Acid Sequence , Animals , Chickens , Humans , Mice , Protein-Arginine N-Methyltransferases/classification , Protein-Arginine N-Methyltransferases/genetics , Sequence AlignmentABSTRACT
We developed a novel BLAST-Based Relative Distance (BBRD) method by Pearson's correlation coefficient to avoid the problems of tedious multiple sequence alignment and complicated outgroup selection. We showed its application on reconstructing reliable phylogeny for nucleotide and protein sequences as exemplified by the fmr-1 gene and dihydrolipoamide dehydrogenase, respectively. We then used BBRD to resolve 124 protein arginine methyltransferases (PRMTs) that are homologues of nine mammalian PRMTs. The tree placed the uncharacterized PRMT9 with PRMT7 in the same clade, outside of all the Type I PRMTs including PRMT1 and its vertebrate paralogue PRMT8, PRMT3, PRMT6, PRMT2 and PRMT4. The PRMT7/9 branch then connects with the type II PRMT5. Some non-vertebrates contain different PRMTs without high sequence homology with the mammalian PRMTs. For example, in the case of Drosophila arginine methyltransferase (DART) and Trypanosoma brucei methyltransferases (TbPRMTs) in the analyses, the BBRD program grouped them with specific clades and thus suggested their evolutionary relationships. The BBRD method thus provided a great tool to construct a reliable tree for members of protein families through evolution.
Subject(s)
Computational Biology/methods , Phylogeny , Protein-Arginine N-Methyltransferases/genetics , Animals , Drosophila melanogaster/enzymology , Protein-Arginine N-Methyltransferases/classification , Sequence Alignment , Sequence Analysis, DNA , Trypanosoma brucei brucei/enzymologyABSTRACT
OBJECTIVE: To observe the expression of protein arginine N-methyltransferase (PRMT) genes in the lung and spleen of E3 rats with acute asthma. METHODS: E3 rats with ovalbumin-induced pulmonary inflammation were divided into two groups (n=10), and the validity of the acute asthma model was evaluated by histological observation with HE and PAS staining and by measurement of NO production. Semi-quantitative RT-PCR was employed to detect the expressions of PRMT1-PRMT6 genes in the lung and spleen tissues of the rats. RESULTS: In the lung tissue of the asthmatic rats, the gene expressions of PRMT1 (P<0.01), PRMT2 (P<0.01), PRMT3 (P<0.05) and PRMT5 (P<0.05) were significantly increased, but the expression of PRMT4 gene (P<0.05) was significantly decreased as compared with those in the control tissue. In the spleen tissue of the asthmatic rats, the expressions of PRMT2 (P<0.05) and PRMT5 genes (P<0.05) showed a significant increase as compared with those in the control rat tissue. CONCLUSION: The gene expressions of PRMTs vary significantly between asthmatic rats and control rats, suggesting that PRMTs play an important role in the post-translational modification process of asthma-related genes.
Subject(s)
Asthma/enzymology , Protein-Arginine N-Methyltransferases/metabolism , Acute Disease , Animals , Female , Male , Protein Processing, Post-Translational , Protein-Arginine N-Methyltransferases/classification , Protein-Arginine N-Methyltransferases/genetics , Random Allocation , Rats , Rats, Inbred StrainsABSTRACT
Information about the family of protein arginine methyltransferases (PRMTs) has been growing rapidly over the last few years and the emerging role of arginine methylation involved in cellular processes like signaling, RNA processing, gene transcription, and cellular transport function has been investigated. To date, 11 PRMTs gene transcripts have been identified in humans. Almost all PRMTs have been shown to have enzymatic activity and to catalyze arginine methylation. This review will summarize the overall function of human PRMTs and include novel highlights on each family member.
Subject(s)
Isoenzymes/metabolism , Protein-Arginine N-Methyltransferases/metabolism , Animals , Arginine/chemistry , Arginine/metabolism , Humans , Isoenzymes/genetics , Methylation , Molecular Structure , Phylogeny , Protein Processing, Post-Translational , Protein-Arginine N-Methyltransferases/classification , Protein-Arginine N-Methyltransferases/genetics , Signal Transduction/physiologyABSTRACT
Posttranslational modifications are well-known effectors of signal transduction. Arginine methylation is a covalent modification that results in the addition of methyl groups to the nitrogen atoms of the arginine side chains. A probable role of arginine methylation in signal transduction is emerging with the identification of new arginine-methylated proteins. However, the functional consequences of arginine methylation and its mode of regulation remain unknown. The identification of the protein arginine methyltransferase family and the development of methylarginine-specific antibodies have raised renewed interest in this modification during the last decade. Arginine methylation was mainly observed on abundant proteins such as RNA-binding proteins and histones, but recent advances have revealed a plethora of arginine-methylated proteins implicated in a variety of cellular processes, including signaling by interferon and cytokines, and in T cell signaling. We discuss these recent advances and the role of arginine methylation in signal transduction.
Subject(s)
Arginine/chemistry , Protein Processing, Post-Translational , Protein-Arginine N-Methyltransferases/physiology , Signal Transduction/physiology , Animals , Consensus Sequence , Drosophila Proteins/physiology , Eukaryotic Cells/metabolism , Humans , Hydrogen Bonding , Hydrolases/metabolism , Hydrophobic and Hydrophilic Interactions , Methylation , NFATC Transcription Factors/metabolism , Phylogeny , Plant Proteins/physiology , Protein Binding , Protein Interaction Mapping , Protein-Arginine Deiminase Type 4 , Protein-Arginine Deiminases , Protein-Arginine N-Methyltransferases/classification , Saccharomyces cerevisiae Proteins/physiology , Substrate SpecificityABSTRACT
Type I protein arginine methyltransferases catalyze the formation of asymmetric omega-N(G),N(G)-dimethylarginine residues by transferring methyl groups from S-adenosyl-L-methionine to guanidino groups of arginine residues in a variety of eucaryotic proteins. The predominant type I enzyme activity is found in mammalian cells as a high molecular weight complex (300-400 kDa). In a previous study, this protein arginine methyltransferase activity was identified as an additional activity of 10-formyltetrahydrofolate dehydrogenase (FDH) protein. However, immunodepletion of FDH activity in RAT1 cells and in murine tissue extracts with antibody to FDH does not diminish type I methyltransferase activity toward the methyl-accepting substrates glutathione S-transferase fibrillarin glycine arginine domain fusion protein or heterogeneous nuclear ribonucleoprotein A1. Similarly, immunodepletion with anti-FDH antibody does not remove the endogenous methylating activity for hypomethylated proteins present in extracts from adenosine dialdehyde-treated RAT1 cells. In contrast, anti-PRMT1 antibody can remove PRMT1 activity from RAT1 extracts, murine tissue extracts, and purified rat liver FDH preparations. Tissue extracts from FDH(+/+), FDH(+/-), and FDH(-/-) mice have similar protein arginine methyltransferase activities but high, intermediate, and undetectable FDH activities, respectively. Recombinant glutathione S-transferase-PRMT1, but not purified FDH, can be cross-linked to the methyl-donor substrate S-adenosyl-L-methionine. We conclude that PRMT1 contributes the major type I protein arginine methyltransferase enzyme activity present in mammalian cells and tissues.